Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,791 | 9,611 | 10,916 | 12,549 | 14,976 |
| Receivables | 331 | 555 | 732 | 824 | 558 |
| Inventories | 482 | 554 | 742 | 723 | 913 |
| Other current assets | 92 | 71 | 126 | 95 | 265 |
| TOTAL | $9,696 | $10,790 | $12,515 | $14,190 | $16,712 |
| Non-Current Assets | |||||
| PPE Net | 1,026 | 1,078 | 1,128 | 1,155 | 728 |
| Intangibles | 3 | 4 | 5 | 7 | 8 |
| Other Non-Current Assets | 79 | 94 | 106 | 119 | 109 |
| TOTAL | $1,107 | $1,175 | $1,240 | $1,280 | $845 |
| Total Assets | $10,803 | $11,966 | $13,755 | $15,470 | $17,558 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 488 | 465 | 501 | 525 | 709 |
| Accrued Expenses | 351 | 283 | 646 | 945 | 82 |
| TOTAL | $893 | $802 | $1,204 | $1,520 | $850 |
| Non-Current Liabilities | |||||
| TOTAL | $51 | $65 | $75 | $94 | $97 |
| Total Liabilities | $944 | $867 | $1,279 | $1,615 | $948 |
| Shareholders' Equity | |||||
| Common Shares | 42,120 | 42,120 | 42,120 | 42,120 | 40,858 |
| Retained earnings | -47,624 | -46,107 | -44,296 | -42,652 | -39,637 |
| Other shareholders' equity | 5,296 | 5,229 | 5,045 | 7,397 | 9,266 |
| TOTAL | $9,859 | $11,099 | $12,476 | $13,855 | $16,610 |
| Total Liabilities And Equity | $10,803 | $11,966 | $13,755 | $15,470 | $17,558 |